Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Eastman Kodak Company    EKDKQ

SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 

WSJ BLOG/Health: A.M. Vitals: FDA Adds a Warning, Removes Another From Statin Labels

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/29/2012 | 03:13pm CET

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Katherine Hobson

The FDA and Statins: The FDA will require drug makers to add to statin labels a warning about a small increase in the risk of increased blood-sugar levels and of diabetes linked to the drugs, the WSJ reports. The labels will also include the information that some patients have experienced an adverse reaction of memory loss and confusion, though that won't be a full-fledged warning. But the FDA also removed a warning about the need for liver-enzyme monitoring from statin labels. Cardiologists tell the paper that most people should keep taking their statins despite the new label information.

Benefit Cuts at Kodak: Eastman Kodak is proposing to end health-care benefits for about 16,000 Medicare-eligible retirees in order to save about $20.5 million annually, the Associated Press reports. Kodak filed for Chapter 11 last month.

Insurer and Physicians' Group Clash: Insurer Blue Shield of California filed a demand for at least $10.5 million in damages from Monarch HealthCare, a physician association that sold its management arm to a unit of UnitedHealth Group, the WSJ reports. Blue Shield alleges that Monarch tried to direct Blue Shield members into competing health plans and that physicians stopped seeing some members, violating the contract between Blue Shield and Monarch. Monarch says it objects to "the mischaracterizations made by Blue Shield," the paper says. The case was submitted for binding arbitration.

The Right Dose of Selenium: A review of previously published research appearing in the Lancet suggests that large doses of selenium supplements could raise the risk for type 2 diabetes, Bloomberg News reports. The author of the review suggests that people with blood selenium levels of 122 micrograms per liter or higher shouldn't supplement with the mineral, which has been associated with a lower risk of some cancers, BN says.

Image: iStockphoto

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

Stocks mentioned in the article : Eastman Kodak Company
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EASTMAN KODAK COMPANY
02/20 EASTMAN KODAK : Kodak showcases latest advances in Stream and ULTRASTREAM Inkjet..
02/16 EASTMAN KODAK : Alamo Drafthouse and Kodak Announce Inaugural “Reel Film D..
02/16 KODAK : Signs ARCHOS as European Tablet Brand Licensee
02/14 EASTMAN KODAK COMPANY (NYSE : KODK) Files An 8-K Departure of Directors or Certa..
02/13 EASTMAN KODAK CO : Change in Directors or Principal Officers (form 8-K)
02/09 EASTMAN KODAK : Patent Issued for Vision-Guided Alignment System (USPTO 9557374)
02/06 EASTMAN KODAK : Modification to a Previous Presolicitation Notice - ORNL Develop..
02/06 EASTMAN KODAK : NRC Receives Event Notification Report on New York State Health ..
02/03 EASTMAN KODAK : Special Notice - ORNL Development Assistance Opportunity for Rol..
01/26 EASTMAN KODAK : Patent Issued for Correction of Periodic Registration Errors (US..
More news
Sector news : Photographic Equipment
02/17 S&P downgrade warning sends Toshiba shares falling
02/16 Toshiba may delay chip auction after widening sale to majority stake - source
02/15 TOSHIBA TO DELAY CHIP BUSINESS SALE : Kyodo
02/06DJSHARP : Snaps Losing Streak -- WSJ
02/04 Chinese industry wants 'win-win' end to U.S. anti-dumping duties on washing m..
More sector news : Photographic Equipment
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Jeff J. Clarke Chief Executive Officer & Director
James V. Continenza Chairman
David Bullwinkle Chief Financial Officer & Senior Vice President
Kim E. VanGelder Chief Information Officer & Senior Vice President
Terry R. Taber Chief Technology Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EASTMAN KODAK COMPANY0.00%635
LARGAN PRECISION CO., ..--.--%20 739
GOPRO INC9.87%1 360
YESTAR HEALTHCARE HOLD..2.94%1 081
Q TECHNOLOGY GROUP CO ..58.25%895
TAMRON CO LTD10.82%495
More Results